Search

Your search keyword '"Sheridan, David"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Sheridan, David" Remove constraint Author: "Sheridan, David" Journal journal of hepatology Remove constraint Journal: journal of hepatology
29 results on '"Sheridan, David"'

Search Results

1. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

3. Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review

4. FibroGENE: A gene-based model for staging liver fibrosis

5. A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis

10. Individual patient data meta-analysis on controlled attenuation parameter for the XL probe in obese patients

11. Expanding the use of the vibration controlled transient elastography in morbid obese patients: validation of a new automated adaptive measurement depths algorithm in a large pooled NAFLD cohort

12. Obesity-specific health-related quality of life in patients with non-alcoholic steatohepatitis: results from the regenerate study

13. Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study

14. SAT-292-Effectively reducing screen failure rate in non-alcoholic fatty liver disease clinical trial using the FibroScan-based FAST score combining liver stiffness, controlled attenuation parameter and AST

15. GS-06-Positive Results from REGENERATE: A Phase 3 International, Randomized, Placebo-Controlled Study Evaluating Obeticholic Acid Treatment for NASH

17. GS-02-Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial

20. PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism

21. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection

24. FRI133 - Durability of treatment response after 1 year of therapy with seladelpar in patients with primary biliary cholangitis (PBC): final results of an international phase 2 study.

25. FRI062 - Expanding the use of the vibration controlled transient elastography in morbid obese patients: validation of a new automated adaptive measurement depths algorithm in a large pooled NAFLD cohort.

26. FRI075 - Individual patient data meta-analysis on controlled attenuation parameter for the XL probe in obese patients.

27. SAT-076-Long term palliative abdominal drains versus large volume paracentesis in refractory ascites due to cirrhosis: a multi-centre feasibility randomised controlled trial (the REDUCe Study).

28. FRI080 - Obesity-specific health-related quality of life in patients with non-alcoholic steatohepatitis: results from the regenerate study.

Catalog

Books, media, physical & digital resources